Diabetes Care, Vol 16, Issue 10 1387-1390, Copyright © 1993 by American Diabetes Association

ARTICLES

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women

D Giugliano, N De Rosa, G Di Maro, R Marfella, R Acampora, R Buoninconti and F D'Onofrio
Department of Gerontology and Metabolic Diseases, Second University of Naples, Italy.

OBJECTIVE--To determine the effects of metformin on blood pressure, left ventricular mass, and some metabolic and endocrine parameters in nondiabetic, obese, hypertensive women. RESEARCH DESIGN AND METHODS--Twelve obese, nondiabetic, hypertensive women received 850 mg metformin 2 times/day for 12 wk and placebo for another 12 wk, according to a double-blind, cross-over, randomized design. All patients were hospitalized 4 times, i.e., before randomization and after each treatment (metformin or placebo), to conduct metabolic and cardiovascular investigations (oral glucose tolerance test, euglycemic clamp associated with indirect calorimetry, and echocardiography). RESULTS--Fasting glucose, HbA1c, fasting and glucose-stimulated insulin, blood pressure and left ventricular mass, cholesterol, triglycerides, and fibrinogen decreased significantly after metformin treatment, whereas high-density lipoprotein cholesterol increased. The improvement in glucose metabolism resulted from increased sensitivity to insulin. CONCLUSIONS--These findings suggest that metformin treatment in obese, nondiabetic, hypertensive women produces a more favorable cardiovascular risk profile.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. R Desilets, S. Dhakal-Karki, and K. C Dunican Role of Metformin for Weight Management in Patients Without Type 2 Diabetes Ann. Pharmacother., June 1, 2008; 42(6): 817 - 826. [Abstract] [Full Text] [PDF]

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms Circulation, April 18, 2006; 113(15): 1888 - 1904. [Abstract] [Full Text] [PDF]

				K. M. Levri, E. Slaymaker, A. Last, J. Yeh, J. Ference, F. D'Amico, and S. A. Wilson Metformin as Treatment for Overweight and Obese Adults: A Systematic Review Ann. Fam. Med, September 1, 2005; 3(5): 457 - 461. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Second World Congress on the Insulin Resistance Syndrome: Hypertension, cardiovascular disease, and treatment approaches Diabetes Care, August 1, 2005; 28(8): 2073 - 2080. [Full Text] [PDF]

				M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390. [Abstract] [Full Text] [PDF]

				D A Stakos, D P Schuster, E A Sparks, C F Wooley, K Osei, and H Boudoulas Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study Heart, May 1, 2005; 91(5): 589 - 594. [Abstract] [Full Text] [PDF]

				I A Adediran, R T Ikem, and M F Borisade Fibrinolytic activity in Nigerian diabetics Postgrad. Med. J., October 1, 2004; 80(948): 610 - 612. [Abstract] [Full Text] [PDF]

				A. Sasali and J. L. Leahy Is Metformin Cardioprotective? Diabetes Care, January 1, 2003; 26(1): 243 - 244. [Full Text] [PDF]

				M. G. Wulffele, A. Kooy, P. Lehert, D. Bets, J. C. Ogterop, B. Borger van der Burg, A. J.M. Donker, and C. D.A. Stehouwer Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes Diabetes Care, December 1, 2002; 25(12): 2133 - 2140. [Abstract] [Full Text] [PDF]

				M. T. Zanella, O. Kohlmann Jr, and A. B. Ribeiro Treatment of Obesity Hypertension and Diabetes Syndrome Hypertension, September 1, 2001; 38(3): 705 - 708. [Abstract] [Full Text] [PDF]

				M. Freemark and D. Bursey The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes Pediatrics, April 1, 2001; 107(4): e55 - e55. [Abstract] [Full Text] [PDF]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				M. Santure, M. Pitre, N. Gaudreault, A. Marette, A. Nadeau, and H. Bachelard Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G682 - G692. [Abstract] [Full Text] [PDF]

				J. D. Peuler Opposing adrenergic actions of intravenous metformin on arterial pressure in female spontaneously hypertensive rats Cardiovasc Res, July 1, 1999; 43(1): 237 - 247. [Abstract] [Full Text] [PDF]

				M. S. Muntzel, I. Hamidou, and S. Barrett Metformin Attenuates Salt-Induced Hypertension in Spontaneously Hypertensive Rats Hypertension, May 1, 1999; 33(5): 1135 - 1140. [Abstract] [Full Text] [PDF]

				S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text]

				M. S. Muntzel, A. Abe, and J. S. Petersen Effects of Adrenergic, Cholinergic and Ganglionic Blockade on Acute Depressor Responses to Metformin in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 618 - 623. [Abstract] [Full Text]

				J. S. Petersen, W. Liu, D. R. Kapusta, and K. J. Varner Metformin Inhibits Ganglionic Neurotransmission in Renal Nerves Hypertension, May 1, 1997; 29(5): 1173 - 1177. [Abstract] [Full Text]

				T. A. Kotchen Attenuation of Hypertension by Insulin-Sensitizing Agents Hypertension, August 1, 1996; 28(2): 219 - 223. [Full Text]

				J. S. Petersen and G. F. DiBona Acute Sympathoinhibitory Actions of Metformin in Spontaneously Hypertensive Rats Hypertension, March 1, 1996; 27(3): 619 - 625. [Abstract] [Full Text]